Showing results (201-210 of 246) with videos related to
Sort By:
Pageof 25
Revue Neurologique|July 21, 2026
A multi-outcome prognostic score for therapeutic responses in multiple sclerosisJ Louet, J Paris, I Faddeenkov, et al.Neurology|May 26, 2004
Long-term outcome of oligodendrogliomasC Lebrun, D Fontaine, A Ramaioli, et al.Genes and Immunity|October 11, 2003
Intercellular adhesion molecule-1: a protective haplotype against multiple sclerosisI Cournu-Rebeix, E Génin, G Lesca, et al.Medical and Pediatric Oncology|January 1, 1993
Cerebral non-Hodgkin's lymphoma discovered when treating Hodgkin's diseaseC Bergeron, P Le Moine, E Le Prise-Fleury, et al.NMR in Biomedicine|June 1, 1989
Limits of tumour treatment follow up by surface coil 31P magnetic resonance spectroscopy. The case of sarcosinamide-CNU treated ependymoblastomaL Le Moyec, E Le Rumeur, F Darcel, et al.Lancet (London, England)|May 30, 2001
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised studyG Comi, M Filippi, F Barkhof, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2002
A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosisR G Ghalie, E Mauch, G Edan, et al.Drugs & Aging|July 1, 1995
Drug-induced seizures in the elderly. Causative agents and optimal managementK L Franson, D P Hay, V Neppe, et al.Journal of Neurology|April 12, 2006
Does subthalamic nucleus stimulation induce apathy in Parkinson's disease?D Drapier, S Drapier, P Sauleau, et al.Journal of Neuroimmunology|May 15, 2010
Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine responseJ Kovalchin, J Krieger, M Genova, et al.Pageof 25